Salemonline Journal

Press Release

Multiple System Atrophy Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Neuramedy Co.,Ltd, ProMIS Neurosciences, Enterin Inc., Nippon

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Multiple System Atrophy pipeline constitutes 20+ key companies continuously working towards developing 22+ Multiple System Atrophy treatment therapies, analysis of

Read Full Article

PI3K Inhibitor Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | OnKure Therapeutics, Eli Lilly, BeiGene, Relay Therapeutics, Rhizen Pharmaceuticals, Curis

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, PI3K Inhibitor pipeline constitutes 20+ key companies continuously working towards developing 25+ PI3K Inhibitor treatment therapies, analysis of Clinical Trials,

Read Full Article

Fanconi Anemia Pipeline 2025: MOA, ROA, and Clinical Trial Insights Explored by DelveInsight | Foresee Pharma, Rocket Pharma, John Diaz, Novartis, Sierra Oncology

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Fanconi Anemia pipeline constitutes 3+ key companies continuously working towards developing 3+ Fanconi Anemia treatment therapies, analysis of Clinical Trials,

Read Full Article

Aspergillosis Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis By DelveInsight | KBio, SCYNEXIS, Matinas BioPharma Holdings, Inc., Cipla/Pulmatrix, Pulmocide, F2G

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Aspergillosis pipeline constitutes 10+ key companies continuously working towards developing 12+ Aspergillosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism

Read Full Article

Mantle Cell Lymphoma Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | PharmaEngine, Jiangsu Hansoh Pharma, Galapagos NV, Miltenyi Biomedicine

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Mantle Cell Lymphoma pipeline constitutes 20+ key companies continuously working

Read Full Article

KRAS Inhibitors Drugs Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Target Population, Revenue, Statistics, MOA, ROA and Companies DelveInsight

KRAS Inhibitors Drugs Market KRAS Inhibitors companies working in the market are Novartis, Roche, Genentech, Verastem Oncology, Revolution Medicines, Cardiff

Read Full Article

MASH Market Forecast 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Statistics, Revenue, Patient Pool, MOA, ROA and Companies by DelveInsight

MASH Market MASH Companies are Hepion Pharmaceuticals, Ionis Pharmaceuticals, Galectin Therapeutics, Novo Nordisk A/S, Cirius Therapeutics, HighTide Biopharma, Boehringer Ingelheim,

Read Full Article

Netherlands Data Center Market Revenue to Reach $3.39 Billion by 2030 – Amsterdam Leads – Exclusive Research by Arizton

Netherlands Data Center Market Research Report by Arizton Get Insights on 135 Existing Data Centers Facilities across the Netherlands According

Read Full Article

Refractory Metastatic Melanoma Pipeline Appears Robust With 4+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

DelveInsight’s, “Refractory Metastatic Melanoma Pipeline Insight, 2025” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Refractory

Read Full Article

Crohn’s Disease Pipeline Appears Robust With 90+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

DelveInsight’s, “Crohn’s Disease Pipeline Insight 2025” report provides comprehensive insights about 90+ companies and 90+ pipeline drugs in Crohn’s Disease

Read Full Article